S.S. Kerwar

3.2k total citations · 1 hit paper
96 papers, 2.7k citations indexed

About

S.S. Kerwar is a scholar working on Molecular Biology, Rheumatology and Immunology and Allergy. According to data from OpenAlex, S.S. Kerwar has authored 96 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 23 papers in Rheumatology and 17 papers in Immunology and Allergy. Recurrent topics in S.S. Kerwar's work include Cell Adhesion Molecules Research (17 papers), Folate and B Vitamins Research (10 papers) and Biochemical and Molecular Research (9 papers). S.S. Kerwar is often cited by papers focused on Cell Adhesion Molecules Research (17 papers), Folate and B Vitamins Research (10 papers) and Biochemical and Molecular Research (9 papers). S.S. Kerwar collaborates with scholars based in United States, China and Netherlands. S.S. Kerwar's co-authors include Arnold L. Oronsky, Susan C. Ridge, Herbert Weissbach, Michael M. Wick, Adolph E. Sloboda, Richard A. McReynolds, Susan Quinn DeJoy, Carlos Spears, Douglas Pat Cerretti and Paul R. Sleath and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

S.S. Kerwar

92 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

1994 524 citations Kendall M. Mohler, Paul R. Sleath et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S.S. Kerwar United States	27	1.0k	704	567	561	417	96	2.7k
Michiyuki Yamada Japan	32	2.4k 2.4×	1.2k 1.7×	713 1.3×	810 1.4×	503 1.2×	65	4.2k
Chin C. Howe United States	22	1.9k 1.9×	278 0.4×	461 0.8×	600 1.1×	201 0.5×	42	3.5k
Thomas Moll United States	30	1.9k 1.9×	1.2k 1.7×	435 0.8×	157 0.3×	498 1.2×	73	3.7k
Robert B. Henderson United Kingdom	21	924 0.9×	1.1k 1.6×	277 0.5×	243 0.4×	420 1.0×	42	2.6k
Noriaki Inamura Japan	26	1.3k 1.3×	807 1.1×	509 0.9×	158 0.3×	209 0.5×	58	3.0k
J Bréard France	17	756 0.7×	1.3k 1.9×	383 0.7×	210 0.4×	237 0.6×	22	2.9k
Toshiharu Nakajima Japan	36	663 0.7×	1.6k 2.3×	576 1.0×	344 0.6×	706 1.7×	80	3.8k
Julius S. Horoszewicz United States	21	1.5k 1.5×	573 0.8×	791 1.4×	158 0.3×	105 0.3×	57	3.7k
H. Haupt Germany	30	1.2k 1.2×	381 0.5×	335 0.6×	174 0.3×	102 0.2×	83	2.4k
Anne M. Fourie United States	18	677 0.7×	529 0.8×	421 0.7×	547 1.0×	321 0.8×	32	2.0k

Countries citing papers authored by S.S. Kerwar

Since Specialization

Citations

This map shows the geographic impact of S.S. Kerwar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.S. Kerwar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.S. Kerwar more than expected).

Fields of papers citing papers by S.S. Kerwar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.S. Kerwar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.S. Kerwar. The network helps show where S.S. Kerwar may publish in the future.

Co-authorship network of co-authors of S.S. Kerwar

This figure shows the co-authorship network connecting the top 25 collaborators of S.S. Kerwar. A scholar is included among the top collaborators of S.S. Kerwar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.S. Kerwar. S.S. Kerwar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elzein, Elfatih, Kevin D. Shenk, Prabha N. Ibrahim, et al.. (2004). Novel inhibitors of fatty acid oxidation as potential metabolic modulators. Bioorganic & Medicinal Chemistry Letters. 14(4). 973–977. 6 indexed citations

Koltun, Dmitry O., Kevin D. Shenk, Elfatih Elzein, et al.. (2003). New fatty acid oxidation inhibitors with increased potency lacking adverse metabolic and electrophysiological properties. Bioorganic & Medicinal Chemistry Letters. 14(2). 549–552. 22 indexed citations

Lum, Robert T., S.S. Kerwar, Stephanie Meyer, et al.. (1998). A New Structural Class of Proteasome Inhibitors that Prevent NF-κB Activation. Biochemical Pharmacology. 55(9). 1391–1397. 31 indexed citations

Munger, William E., Susan Quinn DeJoy, Robert Jeyaseelan, et al.. (1995). Studies Evaluating the Antitumor Activity and Toxicity of Interleukin-15, a New T Cell Growth Factor: Comparison with Interleukin-2. Cellular Immunology. 165(2). 289–293. 177 indexed citations

Mohler, Kendall M., Paul R. Sleath, Jeffrey N. Fitzner, et al.. (1994). Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature. 370(6486). 218–220. 524 indexed citations breakdown →

DeJoy, Susan Quinn, Robert Jeyaseelan, Lawrence W. Torley, et al.. (1994). Effect of CL 184,005, a Platelet-Activating Factor Antagonist in a Murine Model of Staphylococcus aureus-Induced Gram-Positive Sepsis. The Journal of Infectious Diseases. 169(1). 150–156. 9 indexed citations

Schow, Steven R., Susan Quinn DeJoy, Michael M. Wick, & S.S. Kerwar. (1994). Diastereoselective Synthesis of the Antibiotic L-Azatyrosine. The Journal of Organic Chemistry. 59(22). 6850–6852. 13 indexed citations

DeJoy, Susan Quinn, Robert Jeyaseelan, Dennis Powell, et al.. (1993). Studies on the effect of CL 306,293, a substituted quinoline car☐ylic acid, on the clinical disease induced in mice with LP-BM5 virus. Antiviral Research. 20(1). 71–81. 5 indexed citations

Paul, Rolf, William Hallett, J. William Hanifin, et al.. (1993). Preparation of substituted N-phenyl-4-aryl-2-pyrimidinamines as mediator release inhibitors. Journal of Medicinal Chemistry. 36(19). 2716–2725. 27 indexed citations

10.

Trova, Michael P., Allan Wissner, Marion L. Carroll, et al.. (1993). Analogs of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring. Journal of Medicinal Chemistry. 36(5). 580–590. 9 indexed citations

11.

Wissner, Allan, Marion L. Carroll, Bernard D. Johnson, et al.. (1992). Analogs of platelet activating factor. 7. Bis-aryl amide and bis-aryl urea receptor antagonists of PAF. Journal of Medicinal Chemistry. 35(26). 4779–4789. 10 indexed citations

12.

Pickett, Walter C., Lawrence W. Torley, Susan Quinn DeJoy, et al.. (1992). Pluronic F 127 liquid sensitizes mice to low doses of Escherichia coli lipopolysaccharide. Critical Care Medicine. 20(10). 1448–1453. 1 indexed citations

13.

Hynes, John B., G R Westerhof, Gerrit Jansen, et al.. (1991). Synthesis and biological evaluation of a fluorescent analog of folic acid. Biochemistry. 30(23). 5674–5681. 30 indexed citations

14.

Katocs, Andrew S., et al.. (1990). Platelet-Activating Factor or a Platelet-Activating Factor Antagonist Decreases Tumor Necrosis Factor- in the Plasma of Mice Treated with Endotoxin. The Journal of Infectious Diseases. 162(5). 1081–1086. 18 indexed citations

15.

DeJoy, Susan Quinn, et al.. (1990). Studies on the homing of Mycobacterium-sensitized T lymphocytes to the synovium during passive adjuvant arthritis. Cellular Immunology. 130(1). 195–203. 12 indexed citations

16.

DeJoy, Susan Quinn, et al.. (1989). Streptococcal cell wall arthritis. Passive transfer of disease with a T cell line and crossreactivity of streptococcal cell wall antigens with Mycobacterium tuberculosis.. The Journal of Experimental Medicine. 170(2). 369–382. 47 indexed citations

17.

Kerwar, S.S. & Arnold L. Oronsky. (1989). Methotrexate in rheumatoid arthritis: Studies with animal models. Advances in Enzyme Regulation. 29. 247–265. 13 indexed citations

18.

Ferguson, Karen A., Diane H. Boschelli, Philip Hoffman, et al.. (1989). Synergy between 5,10-dideaza-5,6,7,8-tetrahydrofolic acid and methotrexate in mice bearing L1210 tumors. Cancer Chemotherapy and Pharmacology. 25(3). 173–176. 5 indexed citations

19.

DeJoy, Susan Quinn, et al.. (1988). Studies on the synergy between collagen and adjuvant arthritis in rats. Cellular Immunology. 113(1). 117–129. 7 indexed citations

20.

Taurog, Joel D., et al.. (1985). Synergy between adjuvant arthritis and collagen-induced arthritis in rats.. The Journal of Experimental Medicine. 162(3). 962–978. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact